Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for th... read more Featured Products:

3T MRI Scanner

MRI Guided Cardiovascular Intervention System

1.5T MRI Scanner

Mobile 1.5T MRI Scanner

Imaging Software

More products

Download Mobile App

Software Reduces MRI Breath Holding Up to 50%

By MedImaging International staff writers
Posted on 13 May 2013

New software decreases patient magnetic resonance imaging (MRI) breath-hold time up to 50% without surrendering image resolution, enabling ultra-fast, high-quality three-dimensional (3D) T1 imaging.

Siemens Healthcare (Erlangen, Germany) recently reported the US Food and Drug Administration (FDA) recently cleared the company’s CAIPIRINHA (controlled aliasing in volumetric parallel imaging results in higher acceleration) software as part of Siemens’ syngo MR D13A software package for parallel magnetic resonance (MR) imaging. The software helps enable patients with breath-holding difficulties to cut the amount of time they hold their breath without sacrificing imaging resolution or contrast.

Siemens’ CAIPIRINHA software enables acquisition of better quality 3D volumetric interpolated breath-hold sequence (VIBE) T1 images using higher acceleration factors. CAIPIRINHA software will be included as standard with Siemens’ D13A software for Magnetom Aera 1.5 Tesla and Magnetom Skyra 3T MRI systems; it will be available with Siemens’ B19 software as an upgrade for Siemens’ Magnetom Avanto 1.5T and MagnetomVerio 3T systems.

Related Links:
Siemens Healthcare

Visit expo >

Digital Radiography System (Ceiling Free)

Digix CF Series

Ultrasound Table

Women’s Ultrasound EA Table

MRI System

nanoScan MRI 3T/7T

Breast Localization System

MAMMOREP LOOP

Latest MRI News

Channels

Radiography

view channel

Images in a 75-year-old woman who underwent routine screening mammography in 2022. Left mediolateral oblique views shown from prior screening mammograms: (A) 2015, (B) 2018, (C) 2019, and (D) 2021. In (E) 2022, a new mass developed in the left breast at the 6-o’clock position (arrow), with a (F) corresponding irregular mass at US (arrow). Subsequent US-guided core needle biopsy yielded invasive ductal carcinoma, grade 2. The deep learning 5-year risk scores gradually increased from 2.0 (2015) to 2.1 (2018), 3.4 (2019), 3.6 (2021), and 15.3 (2022). CMFN = centimeters from nipple, LT = left, TRANS = transverse (Photo courtesy of Radiological Society of North America)

AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms

Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more

Image: Screening mammograms and artificial intelligence (AI) score changes over time in two individuals with screen-detected cancer. Full-field digital mammograms show craniocaudal (top) and mediolateral (bottom) views of the left and right breast (Photo courtesy of Radiological Society of North America)

AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis

Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read more

$Image: Kyushu University researchers use Dynamic Chest Radiography (DCR) to evaluate the severity of Pulmonary Regurgitation (PR), a common complication after treatment of the congenital heart disease Tetralogy of Fallot. The analysis only requires the patient to hold their breath for seven seconds for a sequence of images of their heart to be taken. The images are then analyzed and extracted into a waveform that can show the severity of PR. The new technique\\\'s detection accuracy of severe PR is 93%, with a sensitivity of 93% and a specificity of 94%. (Photo courtesty of Kyushu University/Yuzo Yamasaki)$